Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASTER DAPT: Abbreviated vs prolonged DAPT after Ultimaster stent in high bleeding risk patients
jRCTs042180003Completed
- Sponsor
- European Cardiovascular Research Institute
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 6
01
Overview
Randomised trial of aspirin, clopidogrel, ticagrelor and prasugrel in coronary arteriosclerosis (2 arms), sponsored by European Cardiovascular Research Institute. Primary endpoints: Net adverse clinical events (NACE), Major adverse cardiac and cerebral events (MACCE) and 1 more. Started Aug 2018; status: completed.
02
Drugs
aspirinclopidogrelticagrelorprasugrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on jRCTs042180003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs042180003.